Sclerotherapy: It Is Back and Better

Clinics in Plastic Surgery

Volumn 38, Issue 3, 2011, Pages 475-487

  Mann, Margaret W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Sclerotherapy; Spider veins; Varicose veins

Indexed keywords

AETHOXY SCLEROL; ASCLERA; CHROMEX; FIBRO VEIN; GLUCOSE PLUS SODIUM CHLORIDE; GLYCEROL; GLYCERYL TRINITRATE; HYALURONIDASE; LIDOCAINE; MONOETHANOLAMINE OLEATE; MORRHUATE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; POLIDOCANOL; POVIDONE IODINE; SCLERODEX; SCLERODINE; SCLEROSING AGENT; SODIUM CHLORIDE; SODIUM CHROMATE; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG; VARIGLOBAN; VARIGLOBIN;

ANAPHYLACTIC SHOCK; ANAPHYLACTOID PURPURA; ANAPHYLAXIS; ASTHMA; BLISTER; BRADYCARDIA; BURNING SENSATION; CARDIOTOXICITY; CHEST TIGHTNESS; COMPRESSION GARMENT; COUGHING; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; ECCHYMOSIS; HAY FEVER; HEMATOMA; HEMATURIA; HEMOLYSIS; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; HYPOTENSION; KIDNEY FAILURE; MIGRAINE; MUSCLE CRAMP; NECROSIS; PAIN; PATIENT EDUCATION; PATIENT SATISFACTION; PATIENT SELECTION; PLEURA EFFUSION; RETICULAR VEIN; REVIEW; SCINTILLATING SCOTOMA; SCLEROTHERAPY; SCOTOMA; SKIN BRUISING; SKIN NECROSIS; SKIN ULCER; SPIDER VEIN; STROKE; SUPERFICIAL THROMBOPHLEBITIS; TELANGIECTASIA; TELANGIECTATIC MATTING; THROMBOEMBOLISM; THROMBOPHLEBITIS; TISSUE NECROSIS; TRANSIENT ISCHEMIC ATTACK; ULCER; URTICARIA; VARICOSIS; VEIN THROMBOSIS; VENOUS REFLUX; VISUAL DISORDER;

ALGORITHMS; HUMANS; POLYETHYLENE GLYCOLS; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; STOCKINGS, COMPRESSION; THROMBOPHLEBITIS; VARICOSE VEINS;

EID: 79961100353     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2011.02.006     Document Type: Review

References (46)

1. Callam M.J. Epidemiology of varicose veins. Br J Surg 1994, 81(2):167-173.
2. Rabe E., Pannier-Fischer F., Gerlach H., et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004, 30:687-693.
3. Drake L.A., Dinehart S.M., Goltz R.W., et al. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol 1996, 34:523-528.
4. Rabe E., Pannier F. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology. Dermatol Surg 2010, 36:968-975.
5. Sadick N.S. Choosing the appropriate sclerosing concentration for vessel diameter. Dermatol Surg 2010, 36:976-981.
6. Goldman M.P., Sadick N.S., Weiss R.A. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 1995, 21:19-29.
7. Weiss R.A., Sadick N.S., Goldman M.P., et al. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999, 25:105-108.
8. Oh T.S., Kim Y.J., Song H.J. Localized hypertrichosis after sclerotherapy. Dermatol Surg 2010, 36:1064-1065.
9. Bergan J.J., Weiss R.A., Goldman M.P. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000, 26:535-542.
10. Zimmet S.E. The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol 1993, 19(7):641-646.
11. Guex J.J. Complications of sclerotherapy: an update. Dermatol Surg 2010, 36:1056-1063.
12. Guex J.J., Schliephake D.E., Otto J., et al. The French polidocanol study on long term side effects: a survey covering 3357 patients years. Dermatol Surg 2010, 36:993-1003.
13. Myers K.A., Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose vein. Eur J Vasc Endovasc Surg 2008, 36:602-605.
14. Guex J.J., Allaert F.A., Gillet J.L., et al. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005, 31:123-128.
15. Bergan J., Pascarella L., Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006, 47:9-18.
16. Gillet J.L., Guedes J.M., Guex J.J., et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009, 24:131-138.
17. Smith P.C. Foam and liquid sclerotherapy for varicose veins. Phlebology 2009, 24(Suppl 1):62-72.
18. Bush R.G., Derrick M., Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008, 23:189-192.
19. Ceulen R.P., Sommer A., Vernooy K., et al. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008, 358:14.
20. Morrison N., Neuhardt D.L., Rogers C.R., et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008, 47:830-836.
21. Hagen P.T., Scholz D.G., Edwards W.D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
22. Breu F.X., Guggenbichler S., Wollmann J.C. 2nd European Consensus Meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa 2008, 37(Suppl 71):1-30.
23. Sadick N., Li C. Small vessel sclerotherapy. Dermatol Clin 2001, 19:473-481.
24. Duffy D.M. Sclerosants: a comparative review. Dermatol Surg 2010, 36:1010-1025.
25. Goldman M.P. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?. Dermatol Surg 2004, 30:1454-1456.
26. Procedures in cosmetic dermatology series 2006, 71-106. Elsevier, The Netherlands. D.M. Duffy, J.T. Hsu, M. Alam (Eds.).
27. Kreussler: Fachinformationen Aethoxysklerol 0,25%/0,5%/1%/2% Stand 06/2005, Aethoxysklerol 3%/4%, Stand 09/2005 [package insert]. Rheingaustraße, Wiesbaden (Germany): Chemische Fabrik Kreussler & Co. GmbH; 2005.
28. Duffy D.M. Varicose veins and telangiectasias diagnosis and treatment. Techniques of small vessel sclerotherapy 1999, 518-547. Quality Medical Publishing, St Louis (MO). M.P. Goldman, R.A. Weiss, J.J. Bergan (Eds.).
29. Rabe E., Schliephake D., Otto J., et al. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology 2010, 25:124-131.
30. Rao J., Wildermore J.K., Goldman M.P. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005, 31:631-635.
31. Goldman M.P. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Dermatol Surg 2002, 28:52-55.
32. Kern P., Ramelet A.A., Wutschert R., et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004, 30:367-372.
33. Leach B.C., Goldman M.P. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg 2003, 29:612-615.
34. Martin D.E., Goldman M.P. A comparison of sclerosing agents: clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerin in the dorsal rabbit ear vein. J Dermatol Surg Oncol 1990, 16:18-22.
35. Foote R.R. Varicose veins 1949, Butterworth & Co, London, p. 1-225.
36. Orbach E.J. The thrombogenic activity of foam of a synthetic anionic detergent (sodium tetradecyl sulfate NNR). Angiology 1950, 1:237-243.
37. Cabrera Garrido J.R., Cabrera Garcia-Olmedo J.R., Garcia-Olmedo Dominguez M.A. Elargissement des limites de la schleotherapie: noveaux produits sclerosants. Phlebologie 1997, 50:181-188. [in French].
38. Monfreux A. Traitement sclérosant des troncs saphéniens et leurscollatérales de gros calibre par la méthode mus. Phlebologie 1997, 50:351-353. [in French].
39. Breu F.X., Guggenbichler S. European consensus meeting on foam sclerotherapy, April 4-6 2003, Tegernsee Germany. Dermatol Surg 2004, 30:709-717.
40. Palm M.D., Guiha I.C., Goldman M.P. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg 2010, 36:1026-1033.
41. Shirazi A.R., Goldman M. The use of a 5-μm filter hub increases foam stability when using the double-syringe technique. Dermatol Surg 2008, 34:91-92.
42. Fraser I.A., Perry E.P., Hatton M., et al. Prolonged bandaging is not required following sclerotherapy of varicose veins. Br J Surg 1985, 72(6):488-490.
43. Moody A.P., Nicklin S., Wilcox A., et al. Prospectively randomised trial of 1 versus 6 weeks of compression after sclerotherapy for varicose veins. Br J Surg 1996, 83(Suppl 1):48.
44. Raj T.B., Makin G.S. A random controlled trial of two forms of compression bandaging in outpatient sclerotherapy of varicose veins. J Surg Res 1981, 31(5):440-445.
45. Shouler P.J., Runchman P.C. Varicose veins: optimum compression after surgery and sclerotherapy. Ann R Coll Surg Engl 1989, 71:402-404.
46. Veraart J.C., Neumann H.A. Effects of medical elastic compression stockings on interface pressure and edema prevention. Dermatol Surg 1996, 22:867-871.